GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:


- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights


GlaxoSmithKline Pharmaceuticals Ltd (GSK India), a subsidiary of GlaxoSmithKline Plc manufactures and markets prescription medicines and vaccines. The prescription medicines includes therapeutic areas such as, analgesic, anti-infective, anti-inflammatory, anti-parasitic, cardiovascular, dermatology, diabetes, endocrine, gastrointestinal, gynaecology, immunosupressants, nutritional, respiratory, central nervous system (CNS) and oncology. The company offers a range of vaccines for the prevention of hepatitis A, hepatitis B, influenzae, diphtheria, tetanus, pertussis, rotavirus, tetanus toxoid, reduced diphtheria toxoid, human papillomavirus vaccine and others. The company is a member of various bodies such as Pharmaceutical Research and Manufacturers of America (PHRMA) and Organisation of Pharmaceutical Producers of India (OPPI). GSK India is headquartered in Mumbai, Maharashtra, India.

GlaxoSmithKline Pharmaceuticals Ltd Key Recent Developments

May 18,2020: GlaxoSmithKline Pharmaceuticals: Change in Directorate
Mar 03,2020: GlaxoSmithKline Pharmaceuticals announce change in directorate
Mar 03,2020: Mr. Sridhar Venkatesh appointed as managing director & VP of GlaxoSmithKline
Oct 09,2019: The Medicine Manufacturing Innovation Centre to develop platform for quicker optimisation of oral solid drug formulations
Jul 22,2019: GlaxoSmithKline Pharmaceuticals financial results for the quarter ended June 30, 2019

Key benefits of buying this profile include:


You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
 


Section 1 - About the Company
GlaxoSmithKline Pharmaceuticals Ltd - Key Facts
GlaxoSmithKline Pharmaceuticals Ltd - Key Employees
GlaxoSmithKline Pharmaceuticals Ltd - Key Employee Biographies
GlaxoSmithKline Pharmaceuticals Ltd - Major Products and Services
GlaxoSmithKline Pharmaceuticals Ltd - History
GlaxoSmithKline Pharmaceuticals Ltd - Company Statement
GlaxoSmithKline Pharmaceuticals Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
GlaxoSmithKline Pharmaceuticals Ltd - Business Description
Geographical Segment: Foreign Countries
Performance
Geographical Segment: India
Performance
GlaxoSmithKline Pharmaceuticals Ltd - Corporate Strategy
GlaxoSmithKline Pharmaceuticals Ltd - SWOT Analysis
SWOT Analysis - Overview
GlaxoSmithKline Pharmaceuticals Ltd - Strengths
GlaxoSmithKline Pharmaceuticals Ltd - Weaknesses
GlaxoSmithKline Pharmaceuticals Ltd - Opportunities
GlaxoSmithKline Pharmaceuticals Ltd - Threats
GlaxoSmithKline Pharmaceuticals Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
GlaxoSmithKline Pharmaceuticals Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 18, 2020: GlaxoSmithKline Pharmaceuticals: Change in Directorate
Mar 03, 2020: GlaxoSmithKline Pharmaceuticals announce change in directorate
Mar 03, 2020: Mr. Sridhar Venkatesh appointed as managing director & VP of GlaxoSmithKline
Oct 09, 2019: The Medicine Manufacturing Innovation Centre to develop platform for quicker optimisation of oral solid drug formulations
Jul 22, 2019: GlaxoSmithKline Pharmaceuticals financial results for the quarter ended June 30, 2019
Jun 19, 2019: Medicines manufacturing innovation centre project to deliver just in time clinical trials
Mar 28, 2019: Appointments to the GlaxoSmithKline Pharmaceuticals board
Feb 04, 2019: GlaxoSmithKline pharmaceutical: Change in Directorate
Feb 04, 2019: GlaxoSmithKline Pharmaceuticals delivers strong Q3 performance with revenue up 17% and PAT higher by 26%
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
 


List Of Tables


GlaxoSmithKline Pharmaceuticals Ltd, Key Facts
GlaxoSmithKline Pharmaceuticals Ltd, Key Employees
GlaxoSmithKline Pharmaceuticals Ltd, Key Employee Biographies
GlaxoSmithKline Pharmaceuticals Ltd, Major Products and Services
GlaxoSmithKline Pharmaceuticals Ltd, History
GlaxoSmithKline Pharmaceuticals Ltd, Joint Venture
GlaxoSmithKline Pharmaceuticals Ltd, Key Competitors
GlaxoSmithKline Pharmaceuticals Ltd, Ratios based on current share price
GlaxoSmithKline Pharmaceuticals Ltd, Annual Ratios
GlaxoSmithKline Pharmaceuticals Ltd, Annual Ratios (Cont...1)
GlaxoSmithKline Pharmaceuticals Ltd, Annual Ratios (Cont...2)
GlaxoSmithKline Pharmaceuticals Ltd, Interim Ratios
GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
GlaxoSmithKline Pharmaceuticals Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 


List Of Figures


GlaxoSmithKline Pharmaceuticals Ltd, Performance Chart (2016 - 2020)
GlaxoSmithKline Pharmaceuticals Ltd, Ratio Charts
GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
 


GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) - Financial and Strategic SWOT Analysis Review market research report available in single user pdf license with Aarkstore Enterprise at USD 125

USD 125 View Report

GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125 View Report

Actelion Pharmaceuticals Ltd - Strategy, SWOT and Corporate Finance Report

Actelion Pharmaceuticals Ltd - Strategy, SWOT and Corporate Finance ReportActelion Pharmaceuticals Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report

USD 175 View Report

Glenmark Pharmaceuticals Ltd (GLENMARK) - Financial and Strategic SWOT Analysis Review

Glenmark Pharmaceuticals Ltd (GLENMARK) - Financial and Strategic SWOT Analysis Review market research report available in single user pdf license with Aarkstore Enterprise at USD 300

USD 300 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available